These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35233560)

  • 21. Analysis of a novel class 1 integron containing metallo-beta-lactamase gene VIM-2 in Pseudomonas aeruginosa.
    Jeong JH; Shin KS; Lee JW; Park EJ; Son SY
    J Microbiol; 2009 Dec; 47(6):753-9. PubMed ID: 20127470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.
    Hong DJ; Bae IK; Jang IH; Jeong SH; Kang HK; Lee K
    Infect Chemother; 2015 Jun; 47(2):81-97. PubMed ID: 26157586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology of outbreak-related pseudomonas aeruginosa strains carrying the novel variant blaVIM-17 metallo-beta-lactamase gene.
    Siarkou VI; Vitti D; Protonotariou E; Ikonomidis A; Sofianou D
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1325-30. PubMed ID: 19164147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unusually High Prevalence of Cosecretion of Ambler Class A and B Carbapenemases and Nonenzymatic Mechanisms in Multidrug-Resistant Clinical Isolates of
    Yaghi J; Fattouh N; Akkawi C; El Chamy L; Maroun RG; Khalil G
    Microb Drug Resist; 2020 Feb; 26(2):150-159. PubMed ID: 31424353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of resistance levels to carbapenems and integron-borne blaIMP-1, blaIMP-7, blaIMP-10 and blaVIM-2 in clinical isolates of Pseudomonas aeruginosa.
    Zhao WH; Chen G; Ito R; Hu ZQ
    J Med Microbiol; 2009 Aug; 58(Pt 8):1080-1085. PubMed ID: 19528141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of the mechanism of drug resistance of VIM-2-type metallo-β-lactamase-producing Acineto- bacter baumannii isolated from burn patients and its homology].
    Xili Y; Yue L; Jianhua Z; Fei G; Dinghong M; Nianyun W; Guohui L; Guanghua G
    Zhonghua Shao Shang Za Zhi; 2015 Jun; 31(3):205-10. PubMed ID: 26564568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
    Er H; Altındiş M; Aşık G; Demir C
    Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of Pseudomonas aeruginosa with class 1 integron carrying blaVIM-2 and blaVIM-4 in the University Clinical Hospital of Bialystok (northeastern Poland).
    Michalska-Falkowska A; Sacha PT; Grześ H; Hauschild T; Wieczorek P; Ojdana D; Tryniszewska EA
    Postepy Hig Med Dosw (Online); 2017 Jul; 71(0):589-594. PubMed ID: 28791953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of the first VIM metallo-beta-lactamase-producing Pseudomonas aeruginosa clinical isolate in Serbia.
    Lepsanovic Z; Libisch B; Tomanovic B; Nonkovici Z; Balogh B; Füzi M
    Acta Microbiol Immunol Hung; 2008 Dec; 55(4):447-54. PubMed ID: 19130752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa.
    López-Pérez M; Haro-Moreno JM; Molina-Pardines C; Ventero MP; Rodríguez JC
    mSphere; 2021 Dec; 6(6):e0083621. PubMed ID: 34817240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbapenem Resistance Determinants Acquired through Novel Chromosomal Integrations in Extensively Drug-Resistant Pseudomonas aeruginosa.
    Janice J; Agyepong N; Owusu-Ofori A; Govinden U; Essack SY; Samuelsen Ø; Sundsfjord A; Pedersen T
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0028921. PubMed ID: 33941520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program.
    Mendes RE; Toleman MA; Ribeiro J; Sader HS; Jones RN; Walsh TR
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4693-702. PubMed ID: 15561846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
    Gutiérrez O; Juan C; Cercenado E; Navarro F; Bouza E; Coll P; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4329-35. PubMed ID: 17938181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial resistance pattern and molecular genetic distribution of metallo-β-lactamases producing
    Farhan SM; Ibrahim RA; Mahran KM; Hetta HF; Abd El-Baky RM
    Infect Drug Resist; 2019; 12():2125-2133. PubMed ID: 31406468
    [No Abstract]   [Full Text] [Related]  

  • 37. [Carbapenemases in Pseudomonas spp].
    Juan Nicolau C; Oliver A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28 Suppl 1():19-28. PubMed ID: 20172419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of antimicrobial resistance mechanisms in carbapenem-resistant
    López-García A; Rocha-Gracia RDC; Bello-López E; Juárez-Zelocualtecalt C; Sáenz Y; Castañeda-Lucio M; López-Pliego L; González-Vázquez MC; Torres C; Ayala-Nuñez T; Jiménez-Flores G; Arenas-Hernández MMP; Lozano-Zarain P
    Infect Drug Resist; 2018; 11():1523-1536. PubMed ID: 30288063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China.
    Li J; Zou M; Dou Q; Hu Y; Wang H; Yan Q; Liu WE
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):35. PubMed ID: 27215335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RESULTS OF MONITORING METALLO-BETA-LACTAMASE-PRODUCING STRAINS OF PSEUDOMONAS AERUGINOSA IN A MULTI-PROFILE HOSPITAL.
    Shamaeva SK; Portnyagina US; Edelstein MV; Kuzmina AA; Maloguloval S; Varfolomeeva NA
    Wiad Lek; 2015; 68(4):546-8. PubMed ID: 26887133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.